The joint winner of the 2008 Nobel Prize for Medicine, Harald zur Hausen, was recognised for his work on the human papilloma virus (HPV), which can lead to cervical cancer.
London-based pharmaceuticals giant AstraZeneca stands to make money from vaccines against HPV because it owns patents on their ingredients.
Bo Angelin, a member of the Nobel Committee, sits on the AstraZeneca board, and Bertil Friedholm, representative of the Nobel Committee at the Karolinska Institutet, reportedly held consulting contracts with the company in 2006.
AstraZeneca also recently begun sponsoring the Nobel website and pro-motional subsidiary, the Times reports.
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.